News | November 20, 2017

Clinical Leader Forum Names Boston and Philadelphia As 2018 Locations

Source: Clinical Leader

Philadelphia Agenda Announcement and Advisory Board Introduction

November 20, 2017, Erie, PA: Life Science Leader and ClinicalLeader.com are excited to announce that Clinical Leader Forum will take place in Boston and Philadelphia in 2018. The Boston event is scheduled for October 3 – 4, 2018 at the State Room Boston. The Philadelphia event is scheduled for May 9-10, 2018 at the Hilton Philadelphia City Avenue.

“Last year we had a successful inaugural conference with more than 40 speakers presenting on the topics of interest to our attendees. This year’s conference will build upon those discussions, with a deeper dive into topics focusing on recruitment, technology, and communication, while adding new topics on partnering with large pharma and moving products through the clinical trials development process,” says Ed Miseta, chief editor at Clinical Leader. “I look forward to the networking and informative discussions that will take place.”

Both 2018 events will each include 8 sessions loaded with takeaways to improve clinical trial outcomes, 25+ speakers with real experience at small-and mid-sized sponsor companies, an intimate exhibition space for meeting-and-greeting potential CRO partners, and plenty of opportunities to network.

"As emerging and mid-sized biopharmas are creating novel molecular approaches to disease and biomarker development at an unprecedented rate, they are unavoidably encountering all the challenges of the evolving clinical trial, regulatory, eClinical, big data, and patient-centric ecosystem,” says Michael W. Young, principal, biomedwoRx: Life Sciences Consulting. “Add to this the impact of shifting reimbursement, market access, and value-based healthcare and you'll understand the critical need for both the content and the unique construct of the Clinical Leader Forum."

“There are many industry events to choose from each year, and it is often difficult to decide on which meeting will yield the highest return on investment,” says Theresa R. Devins, senior associate director, strategic alliances, Boehringer Ingelheim Pharmaceuticals, Inc. “The 2017 Clinical Leader Forum event exceeded my expectations in that it was large enough to include a cross-section of industry stakeholders but small enough to have had time to speak with each and every attendee during the course of the meeting. I am still building on the new contacts made during the 2017 session and look forward to a similar experience in 2018!”

Clinical Leader Boston

Life Science Leader and Clinical Leader are thrilled to announce the expansion of Clinical Leader Forum by adding an event in Boston.

“The Boston/Cambridge area is a thriving hub of small and emerging companies in the life sciences industry. In speaking with readers from Life Science Leader magazine and Clinical Leader, it became clear that our readers would like us to help build a community in the Boston area. With the focus Clinical Leader Forum places on these companies, we felt Boston was the logical place to expand our conference,” says Miseta. “We look forward to bringing our experts on small company clinical challenges to these firms and getting them involved in the discussions.”

Clinical Leader Forum Advisory Committee

A guiding principal for Clinical Leader Forum is to discuss challenges that are most relevant for small-to-mid-sized pharma companies. Leading industry experts will offer advice and knowledge to craft the agenda and will guide panelist invitations.

“The key to a successful conference is having a team of highly engaged advisory board members helping to guide the agenda and discussions. I am thrilled to announce these introductory members of the Clinical Leader Forum Advisory Board and look forward to adding even more. These industry experts have insights into the challenges facing our attendees as well as insights into how to overcome them. They will be a great asset to the conference moving forward,” says Miseta.

Clinical Leader Forum Advisory Committee members include: Theresa Devins, senior associate director, Boehringer Ingelheim; Elise Felicione, senior director, R&D operations innovation, Janssen Pharmaceutical Companies; David Kim, VP business development & executive consultant, Ceritas Solutions; Katie Mazuk, senior director, global head iInvestigator & patient engagement, Johnson & Johnson; Molly Rosano, VP, clinical operations, NuCana BioMed; Anita Treohan, director, program management & clinical operations, ImmusanT; and Michael W. Young, principal, biomedwoRx: Life Sciences Consulting. Click here for the full list of Clinical Leader Form Advisory Committee members.

“The 2018 Clinical Leader Forum is designed to effectively advance the practical understanding of how to thrive in the increasingly complex drug development ecosystem. Both the experience and the vision of the talented Clinical Leader Forum Advisory Board informs and guides the content of this unique conference. Attendees from a broad array of innovative biopharmas at last year's inaugural meeting are still benefitting from their invaluable interactions and have shared their sincere hopes for more of the same this coming May in Philadelphia,” says Young.

Clinical Leader Forum Philadelphia

Clinical Leader Forum enters its second year hosting thought leadership conferences and exhibitions that provide discussions of best practices and focuses on clinical trial challenges impacting sponsor companies and their relationships with CROs and sites. The Philadelphia agenda includes sessions that feature clinical professionals sharing their secrets on how to conduct more efficient and successful clinical trials.

A featured session is Clinical Trials Are Broken. Here’s What We Need To Do To Fix Them. Clinical trials are costly, time consuming and, at times, very inefficient.  The FDA’s Janet Woodcock recently remarked that the clinical trials system is “broken” and there needs to be new ways to collect and utilize patient data.  What can the industry collectively do to make the process better?  This panel features experts on sites, investigators, clinical professionals, and CROs to discuss the efforts we can take to make trials more efficient.  They will address four major problems plaguing clinical trials.

Panelists of this session include: Christine Pierre, president, Society for Clinical Research Sites; Robert Hardi, president, Academy of Physicians in Clinical Research; Jim Kremidas, executive director, Association of Clinical Research Professionals; Doug Peddicord, executive director, Association of Clinical Research Organizations; and moderated by Greg Koski, president, Alliance for Clinical Research Excellence and Safety.

"Because the most useful conferences deliver great content but allow time to have attendees share perspectives with one another, the 2018 Clinical Leader Forum builds on last year's inaugural meeting's outstanding networking design. Business collaboration, solution-sharing, and making new connections are intentful outcomes of this conference," says Young.

A highlighted session on day two of the conference is the keynote speaker, Mark Ridge, VP, clinical development operations, CSL Behring. Ridge will discuss how to use leadership, people, and technology to fix a clinical development program that is quickly headed in the wrong direction.  Ridge turned around the clinical development program at CSL Behring and will tell attendees what was wrong, what changes were made, and what the results of those efforts have been.

Click here to find the full Clinical Leader Forum Philadelphia agenda.

About Clinical Leader Forum

Clinical Leader Forum  focuses on clinical trial challenges impacting sponsor companies and their relationships with CROs and sites. Tailored for executives from small- to mid-size companies (or any sponsor that outsources), the sessions feature clinical professionals sharing their secrets on how to conduct more efficient and successful clinical trials.

About Clinical Leader

Clinical Leader is an online community helping to streamline clinical research by connecting trial sponsors with industry-leading service providers. Our goal is to facilitate connections and foster collaborations in clinical development to help stakeholders conduct better, more efficient trials to get safe medicines to patients faster. The original content on Clinical Leader provides readers with actionable information on clinical research trends, challenges, and best practices. Clinical Leader can provide you with the information you need to more efficiently move your product from discovery through regulatory approval. 

About Life Science Leader

Life Science Leader is an essential business resource for pharma, biotech, and med device executives. It takes a deep dive into industry trends and hot topics that impact the growth of the pharma and biopharma markets. This content comes from exclusive and original interviews with top executives from Big Pharma to emerging biotechs and is designed to provide best practices, actionable information, and valuable business strategies.